Enovix Corporation filed a Form 8-K on November 18, 2026, disclosing the entry into a Warrant Agreement and the distribution of warrants to purchase shares of its common stock to holders of record as of November 13, 2026.

Key Highlights

  • Distribution ratio: Each holder of record receives one Warrant for every four shares of Common Stock held, rounded down to the nearest whole number for any fractional Warrant.
  • Exercise price: Each Warrant entitles the holder to purchase one share of Common Stock at $3.00 per Warrant, payable in cash.
  • Record date: Holders of Common Stock as of the close of business on November 13, 2026 are eligible to receive Warrants.
  • Convertible note holders eligible: Holders of the 3.00% Convertible Senior Notes due 2028 and the 4.75% Convertible Senior Notes due 2030 also receive Warrants without converting their notes, calculated as if they held a number of shares equal to the product of the applicable conversion rate and their aggregate principal amount expressed in thousands.
  • Note-based exercise option: Warrants may also be exercised by delivering $1,000 principal amount of Designated Notes to exercise up to 333 Warrants, subject to certain adjustments; the 2028 Notes have been initially designated as Designated Notes.
  • Standard expiration: Unless the Early Expiration Price Condition is met, Warrants expire at 5:00 p.m. New York City time on April 28, 2028.
  • Warrant Agent: Computershare Inc. and its affiliate Computershare Trust Company, N.A. are serving as Warrant Agent under the Warrant Agreement dated November 18, 2026.

Enovix Warrant Agreement Terms and Early Expiration Conditions

According to the filing, Enovix Corporation (NASDAQ:ENVX) entered into a Warrant Agreement dated November 18, 2026, with Computershare Inc. and Computershare Trust Company, N.A. as Warrant Agent. The Board of Directors had declared the Warrant Distribution on October 28, 2026, as the company previously disclosed. Warrants were distributed on November 18, 2026, to holders of record of Common Stock, par value $0.0001 per share, as of the close of business on November 13, 2026.

The filing states that each Warrant gives the holder the right to purchase one share of Common Stock at an exercise price of $3.00 per Warrant, payable in cash, or alternatively by delivering $1,000 principal amount of Designated Notes to exercise up to 333 Warrants, subject to certain adjustments. The company disclosed that the 2028 Notes have been initially designated as Designated Notes. Holders of the company's 3.00% Convertible Senior Notes due 2028 and 4.75% Convertible Senior Notes due 2030 are also eligible to receive Warrants without converting their notes, calculated on the basis described in the Warrant Agreement.

The filing describes an Early Expiration Price Condition mechanism: if, within any 30 consecutive Trading Day period, 20 Qualifying Trading Days occur (the first of which must fall on or after the first Trading Day immediately following the distribution date), the Expiration Date automatically accelerates to the Scheduled Early Expiration Date. The company retains the sole discretion to set an Alternate Early Expiration Date falling after the Scheduled Early Expiration Date, subject to Additional Price Conditions relating to Daily VWAP on the two consecutive Scheduled Trading Days immediately preceding that date. If the Additional Price Conditions are not met and no new Alternate Early Expiration Date is set, the company disclosed that the Expiration Date will remain April 28, 2028, unless another Early Expiration Price Condition Date subsequently occurs.

What Was Disclosed

Enovix filed an 8-K reporting the execution of a Warrant Agreement and the November 18, 2026 distribution of warrants at a $3.00 exercise price, one warrant per four common shares held as of November 13, 2026, with a standard expiration of April 28, 2028.